Literature DB >> 22088922

Why the spleen is a very rare site for metastases from epithelial cancers.

A Michael Peters1.   

Abstract

It is not known why metastases from epithelial cancers are rare in the spleen, yet common in the other major organs of the reticuloendothelial system in which, like the spleen, leucocytes display a prolonged physiological intravascular transit time. Another unresolved issue that at first seems unrelated to splenic metastases is the inconsistency between the concept of physiological granulocyte disposal through granulocyte ageing and the observation that granulocytes leave the blood in an exponential fashion (half-time 7 h), which implies random disposal. Intravascular granulocytes pass through the spleen with an exponential distribution of transit times (mean 10 min). The spleen is highly active in physiological granulocyte destruction so it is suggested that the variation in times of exposure to the splenic microenvironment converts the age-dependent granulocyte destruction observed ex vivo into the random process observed in vivo, probably through exposure to apoptosis-inducing signals. This leads to the second hypothesis, which is that cancer cells fail to survive in the spleen as a result of these pro-apoptotic signals.
Copyright © 2011. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 22088922     DOI: 10.1016/j.mehy.2011.09.033

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  4 in total

1.  The Rarity of Metastasis to the Spleen - a Phenomenon with an Unknown Mechanism.

Authors:  E S Andryukhova; L A Tashireva; A V Isaeva; S V Vtorushin; M V Zavyalova; V M Perelmuter
Journal:  Bull Exp Biol Med       Date:  2022-10-10       Impact factor: 0.737

Review 2.  Solitary splenic metastasis from nasopharyngeal carcinoma: a case report and systematic review of the literature.

Authors:  Pietro Genova; Francesco Brunetti; Emilie Bequignon; Filippo Landi; Vincenzo Lizzi; Francesco Esposito; Cecile Charpy; Julien Calderaro; Daniel Azoulay; Nicola de'Angelis
Journal:  World J Surg Oncol       Date:  2016-07-15       Impact factor: 2.754

3.  Lobular Carcinoma of the Breast Metastatic to the Spleen and Accessory Spleen: Report of a Case.

Authors:  Gabriel M Groisman
Journal:  Case Rep Pathol       Date:  2016-09-08

4.  Splenectomy during cytoreductive surgery in epithelial ovarian cancer.

Authors:  Hengzi Sun; Xiaoning Bi; Dongyan Cao; Jiaxin Yang; Ming Wu; Lingya Pan; Huifang Huang; Ge Chen; Keng Shen
Journal:  Cancer Manag Res       Date:  2018-09-12       Impact factor: 3.989

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.